Speakers: Heather Wakelee and Nasser Altorki
Heather Wakelee and Nasser Altorki discuss the current position on PD-L1 expression and immune checkpoint inhibition in early-stage, resectable NSCLC.
13-04-2022 | Non-small-cell lung cancer | Video
Speakers: Heather Wakelee and Nasser Altorki
Heather Wakelee and Nasser Altorki discuss the current position on PD-L1 expression and immune checkpoint inhibition in early-stage, resectable NSCLC.